dual PPAR alpha/gamma agonists (Merck & Co)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual PPAR alpha/gamma agonists (Merck & Co)
Drug Alias NameTZD-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsHyperlipidemiasDiabetes Mellitus, Type 2Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasDiabetes Mellitus, Type 2Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A